An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period
Main Article Content
Keywords
acne, nodular acne, lidose-isotretinoin, retinoid
Abstract
Abstract not available.
Disclosures: Study supported by SUN Pharma.
Copyright 2018 SKIN